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Abstract
Background: Animal experiments have shown a protective effect of vitamin C on the formation of gallstones. Few data
in humans suggest an association between reduced vitamin C intake and increased prevalence of gallstone disease. The
aim of this study was to assess the possible association of regular vitamin C supplementation with gallstone prevalence.
Methods: An observational, population-based study of 2129 subjects aged 18-65 years randomly selected from the
general population in southern Germany was conducted. Abdominal ultrasound examination, completion of a
standardized questionnaire, compilation of anthropometric data and blood tests were used. Data were collected in
November and December 2002. Data analysis was conducted between December 2005 and January 2006.
Results:  Prevalence of gallstones in the study population was 7.8% (167/2129). Subjects reporting vitamin C
supplementation showed a prevalence of 4.7% (11/232), whereas in subjects not reporting regular vitamin C
supplementation, the prevalence was 8.2% (156/1897). Female gender, hereditary predisposition, increasing age and
body-mass index (BMI) were associated with increased prevalence of gallstones. Logistic regression with backward
elimination adjusted for these factors showed reduced gallstone prevalence for vitamin C supplementation (odds ratio,
OR 0.34; 95% confidence interval, CI 0.14 to 0.81; P = 0.01), increased physical activity (OR 0.62; 95% CI, 0.42 to 0.94;
P = 0.02), and higher total cholesterol (OR 0.65; 95% CI, 0.52 to 0.79; P < 0.001).
Conclusion: Regular vitamin C supplementation and, to a lesser extent, increased physical activity and total cholesterol
levels are associated with a reduced prevalence of gallstones. Regular vitamin C supplementation might exert a protective
effect on the development of gallstones.
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Background
Disorders of the gallbladder are a major cause of morbid-
ity and a leading indication for hospital admissions in
both the United States and Europe. The economic impact
of gallstone disease in Western industrialized countries is
high [1,2].
Clinical and experimental data reported in the 1970's sug-
gested a potential protective effect of vitamin C on the for-
mation of gallstones [3,4]. Furthermore, animal
experiments have shown that animals deficient in vitamin
C more frequently develop gallstones [5,6].
The role of vitamin C in bile acid biogenesis has mainly
been analysed in guinea pigs [3-9]. Cholesterol is con-
verted to bile acids in the liver, and the rate limiting proc-
ess depends on vitamin C concentration in the
hepatocytes [3,4]. Vitamin C increases the rate of 7α-
hydroxylation of cholesterol [4,7,8]. This reaction is
decreased in ascorbic acid deficiency, resulting in reduced
bile acid biogenesis [4,9]. Supersaturation of bile with
cholesterol precedes the formation of cholesterol gall-
stones and this can be caused by a low rate of cholesterol-
7α-hydroxylation [10]. Guinea pigs receiving ascorbic
acid substitution showed a 15-fold increase in the activity
of cholesterol-7α-hydroxylase compared to those defi-
cient in ascorbic acid [7]. Ascorbic acid deficient animals
more frequently developed cholesterol gallstones [5,6].
A similiar biochemical explanation for increased develop-
ment of gallstones in subjects with vitamin C deficiency as
described in guinea pigs might exist in humans [11].
While Duane et al. showed that short-term subclinical
vitamin C deficiency in five healthy volunteers did not
increase the lithogenic potential of gallbladder bile as it
did in guinea pigs fed a high cholesterol diet, Gustafson et
al. described changes in the bile salt composition and bil-
iary phospholipid levels of vitamin C treated cholesterol
gallstone patients and also found support for the notion
that vitamin C supplementation might influence the con-
ditions of cholesterol gallstone formation in humans
[12,13]. In humans, observational studies have also sug-
gested an association between vitamin C intake and gall-
stone disease [14-17].
The prevalence of gallstone disease in relation to vitamin
C intake has not been studied using ultrasonography in a
randomly selected population. The objective of the
present study was to evaluate the potential association of
regular vitamin C supplement use on gallstone preva-
lence, as assessed by ultrasonography and patient's his-
tory, in a cross-sectional survey of randomly selected
subjects from the general population. In addition, we
sought to evaluate the effect of other potential risk factors
for gallstone disease.
Methods
Study population/Subjects
A total of 4,000 subjects aged 10 to 65 years were ran-
domly selected from a target population of 12,475 inhab-
itants of the city of Leutkirch, Germany for participation
in a health survey in November and December 2002 [18].
The survey included among other objectives the possible
association of vitamin C as well as the association of the
Arg64 variant of the beta3-adrenergic receptor [19] on
gallstone prevalence. Out of the 4,000 subjects, 107 were
excluded for various reasons (unknown current address, n
= 68; not giving informed consent, n = 39). Of 3,893 eli-
gible subjects, 2,445 finally participated in the study
(response rate: 62.8%).
Subjects <18 years (n = 258) were excluded in order to
enhance comparability with other studies. In addition,
subjects were excluded for the following reasons: inability
to adequately assess the gallbladder or otherwise limited
ultrasound examination conditions (n = 26), highly con-
tracted gallbladder due to inadequate pre-examination
fasting period (n = 9), cholecystectomy for gallbladder
polyps (n = 4), or refusal to undergo ultrasound examina-
tion (n = 1). Subjects unable to provide information on
vitamin C supplementation (n = 18) were also excluded.
Thus, the final study population consisted of 2,129 sub-
jects (1,025 males, 48.1%; 1,104 females, 51.9%). The
study was conducted in accordance with the principles of
the Helsinki Declaration and Good Clinical Practice. It
was approved by the ethics committee of the Landesärz-
tekammer Baden-Württemberg. All subjects provided
written informed consent.
Survey methods
All subjects completed a standardized questionnaire
under the supervision of a trained interviewer, including
demographic data, data on medical history, physical activ-
ity, dietary habits (use of supplements, duration and
amount of alcohol consumption), smoking habits, family
history (gallstones, diabetes mellitus, malignancies), and
drug history. Further questions on regular vitamin C sup-
plementation (yes/no and daily/weekly intake) and the
duration of supplementation (<1 year, 1-5 years, >5-10
years, >10 years) were included. Moreover, subjects were
asked about regular medication intake including all vita-
min supplementation products (drug name, dosage dur-
ing the last two weeks).
Body height and weight as well as waist and hip circum-
ference were determined, and body-mass index (BMI) and
waist-to-hip ratio (WHR) were calculated [20].
Data analysis was conducted between December 2005
and January 2006.BMC Gastroenterology 2009, 9:74 http://www.biomedcentral.com/1471-230X/9/74
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Laboratory measurement
Venous blood was drawn with minimal suction under
standardized conditions after at least a 4 hour fast. Total
cholesterol, high-density lipoprotein (HDL) cholesterol
and triglycerides were determined enzymatically on a
Dimension XL (Dade Behring Inc., Newark, DE, U.S.A).
Low-density lipoprotein (LDL) cholesterol was calculated
by the Friedewald formula [21].
Ultrasonography
Ultrasonography was performed by specially trained clin-
ical investigators. In case of disagreement between the first
and the second observer an experienced supervisor (>
4000 ultrasound examinations per year) made the final
decision. Examinations were performed using four identi-
cal HDI 5000 ultrasound scanners (2-5 MHz probe) pro-
vided by Advanced Technology Laboratories Ultrasound
(Philips Medical Systems, P.O. Box 3003, Bothell, WA,
USA). All subjects underwent ultrasound examination
under standardized conditions. If gallstones were
detected, the ability to mobilize the gallstones was tested.
If differentiation between immobile gallstones and adher-
ent polyps was difficult, patients were re-examined in
standing position. Diagnosis of gallstones was made on
the basis of at least one of the following criteria: One or
more hyperechoic structures in the gallbladder with dor-
sal shadow; one or more hyperechoic shadows in the gall-
bladder without dorsal shadow, which by examination in
multiple planes or by attempted mobilization could be
clearly differentiated from other structures; one strongly
hyperechoic structure in the area of the gallbladder with
dorsal shadow but in which the gallbladder lumen is no
longer or only barely visualized; one or more hyperechoic
structures with or without dorsal shadow in the biliary
system; no visualization of the gallbladder lumen in
patients following cholecystectomy for gallstone disease;
presence of a large amount of gallbladder sludge that fills
at least one-quarter of the gallbladder lumen with corre-
sponding dorsal shadow.
Statistical analysis
Absolute and relative frequencies were calculated for cate-
gorical variables. For continuous variables, mean and
standard deviation, and the median, as well as 5th and 95th
percentile were calculated.
Multiple logistic regression was performed in order to
identify risk factors associated with prevalence of gall-
stones [22]. First, the effect of the established risk factors
age, gender, BMI and family history were evaluated. Then,
for each of the following factors vitamin C supplementa-
tion, physical activity, smoking, caffeine and alcohol con-
sumption, total cholesterol, HDL-cholesterol and LDL-
cholesterol concentrations, vegetarian diet, diabetes mel-
litus, waist-to-hip ratio, and inflammatory bowel disease
a multiple logistic model adjusted for age, gender, BMI,
and family history was fitted to identify further potential
risk factors. All factors with P-values < 0.1 were pre-
selected. The pre-selection level of 10% was used in order
to ensure that important factors will not be overlooked.
Pre-selected factors were included in a multiple logistic
regression using backward elimination (selection level
5%) in order to identify important risk factors. During the
modeling process, age, gender, BMI, and family history
were forced into the model. Results are given as Odds
Ratios (OR) together with their 95% confidence intervals
(CI) and p-values. Statistical analysis was performed using
the SAS 8.02 statistical software package (SAS, Heidelberg,
Germany).
Results
A total of 167 persons fulfilled the criteria for gallstone
disease, corresponding to an overall prevalence of 7.8%
(167/2129) (Table 1). Of the 2,129 subjects, 232 (10.9%)
reported regular intake of vitamin C as powder, tablets or
capsules. In this group, the prevalence of gallstones was
4.7% (n = 11). Conversely, in those not taking vitamin C
supplements (n = 1897) prevalence of gallstones was
8.2% (n = 156) (Table 2).
Table 1: Demographic and laboratory characteristics of the study population (n = 2129)
Variable mean (SD) median (5th - 95th percentile)
Age (years), n = 2129 42.5 (± 12.9) 42.0 (20 - 63)
Height (cm), n = 2128 169.4 (± 9.3) 169.2 (154.5 - 185.5)
Weight (kg), n = 2121 76.2 (± 16.0) 74.8 (53.9 - 104.5)
BMI (kg/m2), n = 2120 25.8 (± 4.9) 25.1 (19.4 - 34.8)
Waist (cm), n = 2120 87.7 (± 14.1) 87.0 (67.0 - 112.0)
Hip (cm), n = 2120 103.3 (± 9.7) 102.0 (90.0 - 120.0)
Waist-to-hip ratio, n = 2120 0.85 (± 0.1) 0.84 (0.71 - 0.99)
Total cholesterol (mmol/l), n = 2104 5.5 (± 1.1) 5.5 (3.9 - 7.3)
HDL cholesterol (mmol/l), n = 2051 1.6 (± 0.5) 1.5 (1.0 - 2.4)
LDL cholesterol (mmol/l), n = 1773 3.3 (± 0.9) 3.2 (1.8 - 5.0)
Triglycerides (mmol/l), n = 1934 1.7 (± 1.5) 1.3 (0.5 - 4.4)BMC Gastroenterology 2009, 9:74 http://www.biomedcentral.com/1471-230X/9/74
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Study subjects with regular vitamin C supplementation
were further subdivided into four predefined subgroups
based on the duration of supplementation (n = 3 missing
values). The longer the period of vitamin C supplementa-
tion, the lower was the proportion of subjects with gall-
stones (Figure 1). Subjects without (n = 1,897) and with
vitamin C supplementation (n = 232) showed no remark-
able differences in age, BMI, gender, family history, vege-
tarian diet, alcohol, tobacco, and caffeine consumption,
diabetes mellitus, waist-to-hip ratio, cholesterol and trig-
lyceride levels (Table 3).
Multiple logistic regression analyses
Multiple logistic regression analysis showed a strong asso-
ciation of gallstone prevalence with age (OR 1.06 per year;
95% CI, 1.04 to 1.08; P < 0.001), female gender (OR 2.78;
95% CI, 1.89 to 4.07; P < 0.001), BMI (OR 1.12 per kg/
m2; 95% CI, 1.08 to 1.15; P < 0.001), and a family history
of gallstone disease (OR 1.84; 95% CI, 1.26 to 2.69; P =
0.001) (Table 4).
The influence of other potential factors was assessed after
adjustment for established risk factors (age, gender, BMI
and family history). These factors included regular vita-
min C supplementation, smoking, alcohol and caffeine
consumption, vegetarian diet, lipid concentrations, lei-
sure time physical activity, medication, and diabetes mel-
litus (Table 4). Separate multiple regression analyses
showed a reduced prevalence of gallstones for each of the
following factors: regular vitamin C supplementation (OR
0.36; 95% CI, 0.16 to 0.80; P = 0.01), alcohol consump-
tion (OR 0.64; 95% CI, 0.43 to 0.94; P = 0.02), leisure
time physical activity (OR 0.62; 95% CI, 0.43 to 0.91; P =
0.01), elevated total cholesterol (OR 0.67 per mmol/l;
95% CI: 0.55 to 0.81; P < 0.001), LDL cholesterol (OR
0.69 per mmol/l; 95% CI, 0.55 to 0.86; P = 0.001), and
HDL cholesterol levels (OR 0.63 per mmol/l; 95% CI,
0.39 to 1.03; P = 0.07).
Factors associated with increased gallstone prevalence
included waist circumference (OR 1.03; 95% CI, 1.01 to
1.06; P = 0.03), and waist-to-hip ratio (OR 21.36; 95% CI,
1.41 to 322.54; P = 0.02). After adjustment for established
risk factors, all other factors such as diabetes mellitus, veg-
etarian diet, caffeine consumption, smoking, and triglyc-
erides were not associated with the prevalence of
gallstones (Table 4).
Multiple logistic regression analysis with backward 
elimination
Potential risk factors with P values < 0.1 were pre-selected
and included in a multiple logistic regression with back-
ward elimination, whereby age, gender, BMI, and family
history were forced into the model (Table 5).
Table 2: Prevalence of gallstones (%) (number of subjects with 
gallstones/total number of subjects in the specific group) (n = 
2129)
Age*
18 - 30 years 1.5% (6/409)
>30 - 40 years 3.9% (12/558)
>40 - 50 years 7.8% (38/488)
>50 - 65 years 15.0% (101/674)
Gender
female 10.7% (118/1104)
male 4.8% (49/1025)
Positive family history
yes 12.4% (53/428)
no 6.2% (100/1609)
BMI*
< 18.5 4.0% (2/50)
18.5 - < 25 4.0% (40/1003)
25 - < 30 8.2% (57/694)
30 - < 35 15.3% (42/275)
35 - < 40 24.7% (18/73)
≥ 40 28.0% (7/25)
Vitamin C supplementation
yes 4.7% (11/232)
no 8.2% (156/1897)
Physical activity
≤ 2 h/week 9.4% (111/1179)
> 2 h/week 6.0% (56/936)
Alcohol consumption
yes 6.4% (95/1493)
no 11.4% (67/589)
Caffeine consumption
yes 7.8% (152/1955)
no 8.1% (14/173)
Total cholesterol*
< 4 mmol/l
4 - < 5 mmol/l
6.6% (8/122)
7.5% (41/545)
5 - < 6 mmol/l 7.7% (58/751)
≥ 6 mmol/l 8.0% (55/686)
HDL cholesterol*
< 1 mmol/l 10.9% (32/295)
≥ 1 mmol/l 7.1% (125/1756)
LDL cholesterol*
≥ 4 mmol/l 6.3% (21/333)
< 4 mmol/l 8.2% (118/1440)
Triglycerides*
≥ 2.3 mmol/l 7.2% (28/390)
< 2.3 mmol/l 7.8% (120/1544)
Vegetarian diet
yes 6.1% (4/66)
no 7.9% (162/2053)
Diabetes mellitus
yes 23.7% (14/59)
no 7.4% (153/2064)
Waist circumference* (in cm)
≤ 90 (f)/≤ 100 (m) 4.8% (77/1595)
> 90 (f)/> 100 (m) 17.0% (89/525)
Waist to hip ratio*
≤ 0.8 (f)/≤ 0.9 (m) 4.2% (47/1132)
> 0.8 (f)/> 0.9 (m) 12.0% (119/988)
Smoking
yes 7.0% (81/1154)
no 8.7% (85/973)
*These variables were evaluated as continuous variables in the 
multiple logistic regression f (in females); m (in males)BMC Gastroenterology 2009, 9:74 http://www.biomedcentral.com/1471-230X/9/74
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In this model, waist-to-hip ratio (P = 0.88), HDL choles-
terol (P = 0.80), waist circumference (P = 0.23), and alco-
hol consumption (P = 0.21) were eliminated through
backward elimination. Only regular vitamin C supple-
mentation (OR 0.34; 95% CI, 0.14 to 0.81; P = 0.01),
physical activity (OR 0.62; 95% CI, 0.42 to 0.94; P = 0.02)
and total cholesterol (OR 0.65 per mmol/l; 95% CI, 0.52
to 0.79; P < 0.001) remained in the model (Table 5).
Discussion
To our knowledge, this is the first survey in a randomly
selected population sample to investigate the relationship
between vitamin C supplement use and gallstone preva-
lence. Regarding protective factors, we found the strongest
association with lower gallstone prevalence for subjects
with regular vitamin C supplementation. As in other sur-
veys, data from our study confirmed established risk fac-
tors for gallstone disease such as female gender, age, BMI,
and a positive family history [23-25]
To date, observational studies partly conducted in selected
populations, and studies relying on self-reported gall-
stone disease have suggested an association between vita-
min C intake and gallstone prevalence [14-16,26]. In
those studies, where the diagnosis of cholelithiasis was
based solely on patients' reported history with no corrob-
orating imaging data, missing data on asymptomatic gall-
stones might have resulted in a bias.
A small case-control study showed an association between
dietary vitamin C intake and gallstone disease in women,
which, however, was no longer statistically important in
multiple logistic regression analysis [14]. Simon et al.
reported an association between vitamin C supplementa-
tion and the prevalence of gallbladder disease and chole-
cystectomy in women with coronary heart disease [26].
In a subanalysis of NHANES II, a U-shaped relationship
between subjects' ascorbic acid levels and the prevalence
Table 3: Characterization of subjects in relation to vitamin C supplementation (n = 2129)
No Vitamin C supplementation
(n = 1897)
Vitamin C
supplementation
(n = 232)
Age (years)* 42.4 (± 12.9) 43.4 (± 12.8)
BMI (kg/m2)* 25.8 (± 4.9) 25.2 (± 4.8)
Gender
female 985 (51.9%) 119 (51.3%)
male 912 (48.1%) 113 (48.7%)
Positive family history
yes 381 (21.0%) 47 (20.8%)
no 1430 (79.0%) 179 (79.2%)
Physical activity
yes 811 (43.0%) 125 (54.8%)
no 1076 (57.0%) 103 (45.2%)
Vegetarian
yes 57 (3.0%) 9 (3.9%)
no 1830 (97.0%) 223 (96.1%)
Alcohol consumption
yes 1316 (71,1%) 177 (76.6%)
no 535 (28.9%) 54 (23.4%)
Smoking
yes 1026 (54.1%) 128 (55.2%)
no 869 (45.9%) 104 (44.8%)
Caffeine consumption
yes 1740 (91.8%) 215 (92.7%)
no 156 (8.2%) 17 (7.3%)
Diabetes mellitus
yes 54 (2.9%) 5 (2.2%)
no 1838 (97.2%) 226 (97.8%)
Waist circumference (cm)* 87.8 (± 14.1) 87.0 (± 14.0)
Waist-to-hip ratio* 0.85 (± 0.09) 0.84 (± 0.09)
Total cholesterol (mmol/l)* 5.51 (± 1.07) 5.53 (± 1.04)
HDL cholesterol (mmol/l)* 1.58 (± 0.45) 1.60 (± 0.41)
LDL cholesterol (mmol/l)* 3.25 (± 0.94) 3.29 (± 0.95)
Triglycerides (mmol/l)* 1.70 (± 1.54) 1.61 (± 2.72)
*Mean (SD)BMC Gastroenterology 2009, 9:74 http://www.biomedcentral.com/1471-230X/9/74
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of reported gallbladder disease in women was shown
[15]. Data from NHANES III showed an inverse relation-
ship between ascorbic acid levels and gallbladder disease
in women [16].
In addition to vitamin C intake, regular physical activity
might play a role in gallstone disease. Leitzmann et al.
have shown that regular physical activity reduces the risk
of cholecystectomy in women [27]. Other studies have
shown a reduced gallbladder stone prevalence in physi-
cally active subjects [28-31]. In a prospective study, in
which 45,813 male health professionals participated,
those engaging in an average of two to three hours of
moderate running per week seemed to reduce their risk for
newly symptomatic gallstone disease by 20-40%. [28].
Similarly, our study shows a clear inverse association
between physical activity and the prevalence of gallstones,
with a 40% reduced risk in those being active more than
two hours per week (OR 0.62; 95% CI, 0.42 to 0.94; P =
0.02).
Our data also showed a reduced prevalence of gallstones
for higher total cholesterol concentrations. However this
effect, was less pronounced than for vitamin C supple-
mentation. Descriptive analysis revealed an increase in the
prevalence of gallstones with increasing cholesterol con-
centrations. Multiple logistic regression, however, showed
the opposite direction after adjusting for age, gender, BMI,
and family history of gallstone disease. As in our study,
this inverse association between plasma cholesterol con-
centration and gallstone prevalence was shown in other
studies, although the data on the relationship of dietary
cholesterol and cholesterol gallstones is not conclusive
[32-34].
Gallstone prevalence and duration of vitamin C supplementation (n = 2,126) Figure 1
Gallstone prevalence and duration of vitamin C supplementation (n = 2,126).
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Limitations of the study
A limitation of the present study that has to be considered
is the lack of plasma ascorbic acid level measurements.
Whether a single determination of plasma levels of vita-
min C, however, reflects regular vitamin C intake is con-
troversial. A meta-analysis has shown that different
groups of subjects require different amounts of vitamin C
in order to achieve the same plasma level [35,36]. The
determination and comparison of plasma vitamin C lev-
els measured in different laboratories also remains prob-
lematic [37].
Since multiple determinations of plasma vitamin C levels
for assessing subjects' actual vitamin C status were not
possible in our study, we opted against obtaining an one-
time determination. It can be assumed that subjects with
regular intake of vitamin C preparations would show ade-
quate plasma concentrations [35]. In subjects without
vitamin C supplementation, plasma levels depend
directly on their dietary vitamin C intake. Since this can be
quite variable, there is no reliable way to predict plasma
levels of vitamin C. As it is difficult to assess the intake of
natural vitamin C in a large population sample, no
detailed information on vitamin C rich diets apart from
the precisely documented data on supplementation was
recorded in our study.
Considering the possibility that, in subjects without regu-
lar vitamin C supplementation, there might exist a sub-
group taking a natural diet rich in vitamin C, the
Table 4: Multiple logistic regression of established and potential risk factors for gallstone prevalence
Variable Odds Ratio 95% CI P - value
Model including established risk factors only:
Age (per year) 1.06 1.04 - 1.08 < 0.001
Female gender 2.78 1.89 - 4.07 < 0.001
Positive family history 1.84 1.26 - 2.69 0.001
BMI (per kg/m2) 1.12 1.08 - 1.15 < 0.001
Separate models for each of the factors adjusted for the established risk factors:
Vitamin C supplementation (yes) 0.36 0.16 - 0.80 0.01
Vegetarian (yes) 1.19 0.41 - 3.50 0.75
Caffeine consumption (yes) 0.74 0.40 - 1.38 0.35
Alcohol consumption (yes) 0.64 0.43 - 0.94 0.02
Smoking (yes) 1.06 0.74 - 1.52 0.77
Diabetes mellitus (yes) 1.58 0.76 - 3.30 0.22
Waist circumference (per cm) 1.03 1.01 - 1.06 0.03
Waist-to-hip ratio (per unit) 21.36 1.41 - 322.54 0.02
Total cholesterol (per mmol/l) 0.67 0.55 - 0.81 < 0.001
Triglycerides (per mmol/l) 0.91 0.79 - 1.04 0.18
HDL cholesterol (per mmol/l) 0.63 0.39 - 1.03 0.06
LDL cholesterol (per mmol/l) 0.69 0.55 - 0.86 0.001*
Leisure time physical activity
(> 2 hours/week)
0.62 0.43 - 0.91 0.01
bold = pre-selected risk factors with P < 0.10
* = factor not pre-selected due to large number of missing values
Table 5: Results of multiple logistic regression analysis with backward elimination of potential factors after adjustment for established 
risk factors
Variable Odds Ratio 95% CI P - value
Factors forced into the model:
Age (per year) 1.07 1.05 - 1.10 < 0.001
Female gender (yes) 3.74 2.15 - 6.51 < 0.001
Positive family history (yes) 1.82 1.21 - 2.76 0.005
BMI (per kg/m2) 1.04 0.95 - 1.14 0.37
Selected risk factors:
Vitamin C supplementation (yes) 0.34 0.14 - 0.81 0.01
Physical activity (> 2 hours/week) 0.62 0.42 - 0.94 0.02
Cholesterol (per mmol/l) 0.65 0.52 - 0.79 < 0.001BMC Gastroenterology 2009, 9:74 http://www.biomedcentral.com/1471-230X/9/74
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difference in gallstone prevalence between subjects with
high vitamin C intake (natural or through supplementa-
tion) and subjects with low vitamin C intake might be
even more pronounced.
Conclusion
Our study provides evidence that regular vitamin C sup-
plementation is associated with reduced prevalence of
gallstones. This observation is supported by data from
animal experiments reported in the literature. A biochem-
ical relationship has also been identified. Thus, it seems
reasonable to postulate a possible protective effect of vita-
min C on the formation of gallstones.
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